Literature DB >> 8545824

Comparative in vitro methylation of trivalent and pentavalent arsenicals.

M Styblo1, H Yamauchi, D J Thomas.   

Abstract

The time course and extent of methylation of 1 microM arsenite (iAsIII), arsenate (iAsV), methylarsenite (MeAsIII), methylarsenate (MeAsV), and MeAsIII-diglutathione complex (MeAsIII(GS)2) were examined in an in vitro assay system that contained rat liver cytosol. Precursor arsenicals and methylated metabolites were analyzed by thin-layer chromatography (TLC) or by hydride generation-atomic absorption spectrophotomoetry (HG-AAS). More than 90% of iAsIII was converted to a dimethylated species (Me2As) during a 90-min incubation at 37 degrees C; the amount of monomethylated metabolite was maximal at 15 min. In contrast, only 40% of iAsV was dimethylated during a 90-min incubation. Comparison of the yields of methylated species in the whole in vitro assay system as determined by HG-AAS and in an ultrafiltrate prepared from the in vitro assay system as determined by TLC indicated that nearly 70% of the dimethylated metabolite (possibly Me2AsIII) that was produced during a 90-min incubation was bound to proteins (> 10 kDa). The percentage of protein-bound arsenic in the assay system incubated at 0 degree C with trivalent arsenicals was three-to fivefold greater than the binding of corresponding pentavalent species. This indicated that both iAsIII and trivalent organoarsenicals interact avidly with proteins. Both MeAsIII prepared by metabisulfite-thiosulfate reduction of MeAsV and a MeAsIII(GS)2 were quantitatively converted to Me2As during 90-min incubation. In contrast, only 3% of MeAsV was dimethylated during this interval. These results suggest that trivalent arsenicals are preferred substrates for methylation reactions and that the reduction of As from pentavalent to trivalent states may be a critical step in the control of the rate of metabolism of As.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8545824     DOI: 10.1006/taap.1995.1220

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  17 in total

1.  Expression of AS3MT alters transcriptional profiles in human urothelial cells exposed to arsenite.

Authors:  Sd Hester; Z Drobná; Dmk Andrews; J Liu; Mp Waalkes; Dj Thomas; M Styblo
Journal:  Hum Exp Toxicol       Date:  2009-01       Impact factor: 2.903

2.  In vitro assays of inorganic arsenic methylation.

Authors:  Zuzana Drobna; Miroslav Styblo; David J Thomas
Journal:  Curr Protoc Toxicol       Date:  2009-11

3.  Tissue dosimetry, metabolism and excretion of pentavalent and trivalent monomethylated arsenic in mice after oral administration.

Authors:  Michael F Hughes; Vicenta Devesa; Blakely M Adair; Miroslav Styblo; Elaina M Kenyon; David J Thomas
Journal:  Toxicol Appl Pharmacol       Date:  2005-10-15       Impact factor: 4.219

4.  Environmentally relevant concentrations of arsenite and monomethylarsonous acid inhibit IL-7/STAT5 cytokine signaling pathways in mouse CD3+CD4-CD8- double negative thymus cells.

Authors:  Huan Xu; Fredine T Lauer; Ke Jian Liu; Laurie G Hudson; Scott W Burchiel
Journal:  Toxicol Lett       Date:  2016-02-24       Impact factor: 4.372

5.  High-throughput screening-compatible assays of As(III) S-adenosylmethionine methyltransferase activity.

Authors:  Hui Dong; Wenzhong Xu; Jitesh K Pillai; Charles Packianathan; Barry P Rosen
Journal:  Anal Biochem       Date:  2015-04-10       Impact factor: 3.365

6.  shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells.

Authors:  Zuzana Drobna; Weibing Xing; David J Thomas; Miroslav Stýblo
Journal:  Chem Res Toxicol       Date:  2006-07       Impact factor: 3.739

7.  Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase.

Authors:  Zuzana Drobná; Stephen B Waters; Vicenta Devesa; Anne W Harmon; David J Thomas; Miroslav Stýblo
Journal:  Toxicol Appl Pharmacol       Date:  2005-09-01       Impact factor: 4.219

8.  Pharmacokinetic modeling of arsenite uptake and metabolism in hepatocytes--mechanistic insights and implications for further experiments.

Authors:  Michael R Easterling; Miroslav Styblo; Marina V Evans; Elaina M Kenyon
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-06       Impact factor: 2.745

9.  Development of mass spectrometric methods for detecting arsenic-glutathione complexes.

Authors:  Katerina Kanaki; Spiros A Pergantis
Journal:  J Am Soc Mass Spectrom       Date:  2008-06-28       Impact factor: 3.109

Review 10.  High arsenic groundwater: mobilization, metabolism and mitigation--an overview in the Bengal Delta Plain.

Authors:  Rupa Bhattacharyya; Debashis Chatterjee; Bibhash Nath; Joydev Jana; Gunnar Jacks; Marie Vahter
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.